My main research goals are to establish the information of genome-wide epigenetic changes and identification of genetic marker involved in diseases for improved diagnosis. During my Ph.D. program, I was involved in numerous studies and publications related to antioxidant, anti-inflammatory, memory enhancement, and neuroprotective activity from primarily natural resources. My Ph.D. research has enhanced my understanding of molecular and cellular biology and has given me additional experience and technical training in various in vivo and in vitro experiments. Moreover, it provided me with working knowledge in immunology and pharmacology. Since I have joined my current group, I have developed a strong interest in epigenetics, molecular epidemiology, transcriptional modification, and its implications for Alzheimer’s disease. I gained the extensive expertise for my interest in areas such as chromatin immunoprecipitation (ChIP), ChIP-seq, RNA-seq and computational analysis. I have generated genome wide transcriptional and epigenetic profiling in response to various risk factors from different cell types and Alzheimer's disease mice models. The proposed research builds on our preliminary research and will provide understanding the development of Alzheimer’s disease in response to various risk factors and potential therapeutic strategies.